Literature DB >> 1583125

Measurement of fecal lactoferrin as a marker of fecal leukocytes.

R L Guerrant1, V Araujo, E Soares, K Kotloff, A A Lima, W H Cooper, A G Lee.   

Abstract

While diarrheal illnesses are extremely common in communities and hospitals throughout the world, an etiologic diagnosis may be expensive and cost-ineffective. Although the presence of fecal leukocytes are helpful in the diagnosis and specific therapy of inflammatory diarrheas, this requires prompt microscopic examination of fecal specimens (preferably obtained in a cup rather than a swab or diaper) by a trained observer. We developed a simple, sensitive test for the detection of leukocytes in fecal specimens using antilactoferrin antibody. Whereas radial immunodiffusion detected 0.02 micrograms of lactoferrin (LF) per microliter or greater than or equal to 2,000 leukocytes per microliter, latex agglutination (LA) readily detected greater than or equal to 0.001 micrograms of LF per microliter or greater than or equal to 200 leukocytes per microliter added to stool specimens. Despite the destruction or loss of morphologic leukocytes on storage for 1 to 7 days at 4 degrees C or placement of specimens on swabs, measurable LF remained stable. Initial studies of stool specimens from six patients with Salmonella or Clostridium difficile enteritis were positive and those from three controls were negative for LF by LA. Of 17 children in Brazil with inflammatory diarrhea (greater than or equal to 1 leukocyte per high-power field), 16 (94%) had LF titers of greater than 1:50 by LA, whereas only 3 of 12 fecal specimens with less than 1 leukocyte per high-power field on methylene blue examination and none of 7 normal control specimens had an LF titer of greater than 1:50 by LA. Of 16 fecal specimens from patients with C. difficile diarrhea (cytotoxin titers, >/= 1:1,000), 95% (n = 15) had detectable LF by LA (in titers of 1:100 to 1: 800). Finally, of 48 fecal specimens from healthy adult U.S. volunteers before and after experimental shigellosis and of 29 fecal specimens from children with documented shigellosis and hospitalized controls in northeastern Brazil, fecal LF titers ranged from 1:200 to >/= 1:5,000 in 96% (25 of 26) samples from patients with shigellosis (and reported positive for fecal leukocytes), while 51 controls consistently had fecal LF titers of </= 1:200. We conclude that fecal LF is a useful marker for fecal leukocytes, even when they are morphologically lost swab specimens or when they are destroyed on transport or storage or by cytotoxic fecal specimens.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1583125      PMCID: PMC265257          DOI: 10.1128/jcm.30.5.1238-1242.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  19 in total

Review 1.  Acute infectious diarrhea. II. Diagnosis, treatment and prevention.

Authors:  E K Williams; J A Lohr; R L Guerrant
Journal:  Pediatr Infect Dis       Date:  1986 Jul-Aug

2.  Leukocyte esterase activity and nitrite test as a rapid screen for significant bacteriuria.

Authors:  R Oneson; D H Gröschel
Journal:  Am J Clin Pathol       Date:  1985-01       Impact factor: 2.493

Review 3.  Diarrhea in developed and developing countries: magnitude, special settings, and etiologies.

Authors:  R L Guerrant; J M Hughes; N L Lima; J Crane
Journal:  Rev Infect Dis       Date:  1990 Jan-Feb

4.  An enzyme-linked immunoassay (ELISA) for measurement of lactoferrin.

Authors:  S V Hetherington; J K Spitznagel; P G Quie
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

5.  Lactoferrin--specific localization in the nuclei of human polymorphonuclear neutrophilic leukocytes.

Authors:  I Green; C H Kirkpatrick; D C Dale
Journal:  Proc Soc Exp Biol Med       Date:  1971-09

6.  Differential clinical features and stool findings in shigellosis and amoebic dysentery.

Authors:  P Speelman; R McGlaughlin; I Kabir; T Butler
Journal:  Trans R Soc Trop Med Hyg       Date:  1987       Impact factor: 2.184

7.  Evaluation and diagnosis of acute infectious diarrhea.

Authors:  R L Guerrant; D S Shields; S M Thorson; J B Schorling; D H Gröschel
Journal:  Am J Med       Date:  1985-06-28       Impact factor: 4.965

8.  Value of stool cultures.

Authors:  J P Koplan; H V Fineberg; M J Ferraro; M L Rosenberg
Journal:  Lancet       Date:  1980-08-23       Impact factor: 79.321

9.  Preliminary observations on lactoferrin secretion in human vaginal mucus: variation during the menstrual cycle, evidence of hormonal regulation, and implications for infection with Neisseria gonorrhoeae.

Authors:  M S Cohen; B E Britigan; M French; K Bean
Journal:  Am J Obstet Gynecol       Date:  1987-11       Impact factor: 8.661

10.  Lactoferrin, an iron-binding protein in neutrophilic leukocytes.

Authors:  P L Masson; J F Heremans; E Schonne
Journal:  J Exp Med       Date:  1969-09-01       Impact factor: 14.307

View more
  52 in total

1.  Usefulness of fecal lactoferrin in predicting and monitoring the clinical severity of infectious diarrhea.

Authors:  Chien-Chang Chen; Chee-Jen Chang; Tzou-Yien Lin; Ming-Wei Lai; Hsun-Chin Chao; Man-Shan Kong
Journal:  World J Gastroenterol       Date:  2011-10-07       Impact factor: 5.742

Review 2.  Diagnostic accuracy of fecal lactoferrin for inflammatory bowel disease: a meta-analysis.

Authors:  Yan Wang; Fengyan Pei; Xingjuan Wang; Zhiyu Sun; Chengjin Hu; Hengli Dou
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

Review 3.  Enteric infections, diarrhea, and their impact on function and development.

Authors:  William A Petri; Mark Miller; Henry J Binder; Myron M Levine; Rebecca Dillingham; Richard L Guerrant
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

4.  Infectious disease physicians rate microbiology services and practices.

Authors:  E J Baron; D Francis; K M Peddecord
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

Review 5.  Diarrhea, demography and cell signaling: lessons from microbial toxins.

Authors:  R L Guerrant; A A Lima; N M Thielman; T S Steiner; M C Fonteles
Journal:  Trans Am Clin Climatol Assoc       Date:  1997

Review 6.  Noninvasive methods in evaluation of inflammatory bowel disease: where do we stand now? An update.

Authors:  Cansel Turkay; Benan Kasapoglu
Journal:  Clinics (Sao Paulo)       Date:  2010-02       Impact factor: 2.365

7.  Characterization and studies of the cellular interaction of native colonization factor CS6 purified from a clinical isolate of enterotoxigenic Escherichia coli.

Authors:  Abhisek Ghosal; Rudra Bhowmick; Rajat Banerjee; Sandipan Ganguly; S Yamasaki; T Ramamurthy; T Hamabata; Nabendu Sekhar Chatterjee
Journal:  Infect Immun       Date:  2009-02-23       Impact factor: 3.441

8.  Measurement of urinary lactoferrin as a marker of urinary tract infection.

Authors:  S Arao; S Matsuura; M Nonomura; K Miki; K Kabasawa; H Nakanishi
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

9.  To culture or not to culture: fecal lactoferrin screening for inflammatory bacterial diarrhea.

Authors:  S W Choi; C H Park; T M Silva; E I Zaenker; R L Guerrant
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

Review 10.  Diagnosis and treatment of bacterial diarrhea.

Authors:  James V Lawler; Mark R Wallace
Journal:  Curr Gastroenterol Rep       Date:  2003-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.